Author: HealthDay

By Dennis Thompson HealthDay ReporterTHURSDAY, Aug. 14, 2025 (HealthDay News) — Advanced technology has boosted the ability of children and adults to manage their type 1 diabetes, a new study says. The number of kids under 18 who’ve achieved optimal control over their blood sugar skyrocketed 171%Read More

Read More

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today reported financial results for the quarter ended June 30, 2025, and provided a business and clinical update.Read More

Read More